Home

Angie You

CIK 1647664 · Chief Bus. & Strat. Officer · last filed 2026-08-06

Angie You is a Chief Bus. & Strat. Officer who has filed 15 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for ATTO, was dated Aug 6, 2026. Across all open-market trades the lifetime net is +$305.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $320.2K across reported positions. 2 SEC filings were submitted jointly with Attovia Therapeutics, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$320.2K

Companies

5

Total Filings

15

Lifetime Open-Market Net

$305.8K

Filer Profile

Reported Address
C/O AMUNIX PHARMACEUTICALS, INC.
2 TOWER PLACE, #1100
SOUTH SAN FRANCISCO, CA 94080
Related Filers
Attovia Therapeutics, Inc. — 2 joint filings, latest 2026-08-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ATTO Director — $22.79 — $0 2 2026-08-06
ORIC Director 26,597 $12.04 $320.2K $262.9K 7 2026-01-06
RayzeBio, Inc. (RYZB) Delisted Director — $62.49 — $0 1 2024-02-27
Sierra Oncology, Inc. (SRRA) Delisted Chief Bus. & Strat. Officer 3,331 $54.99 $183.2K $42.9K 3 2018-03-07
Sierra Oncology, Inc. (DNAI) Delisted Chief Bus. & Strat. Officer — — — $0 2 2016-10-04

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-06 ATTO Grant (A) — $0 EDGAR
2026-08-06 ATTO Grant (A) — $0 EDGAR
2026-01-06 ORIC Grant (A) — $0 EDGAR
2025-06-23 ORIC Buy (P) +28,000 $262.9K EDGAR
2025-01-06 ORIC Grant (A) — $0 EDGAR
2024-06-14 ORIC Grant (A) — $0 EDGAR
2024-02-27 RayzeBio, Inc. (RYZB) Delisted Disp (D) — $0 EDGAR
2023-06-15 ORIC Grant (A) — $0 EDGAR
2022-06-17 ORIC Grant (A) — $0 EDGAR
2021-11-10 ORIC Grant (A) — $0 EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.